376 related articles for article (PubMed ID: 23275444)
1. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
[TBL] [Abstract][Full Text] [Related]
2. STAT3 or USF2 contributes to HIF target gene specificity.
Pawlus MR; Wang L; Murakami A; Dai G; Hu CJ
PLoS One; 2013; 8(8):e72358. PubMed ID: 23991099
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X; Hicks KC; Neumann P; Patel TB
PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
[TBL] [Abstract][Full Text] [Related]
4. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.
Sena JA; Wang L; Hu CJ
Mol Cell Biol; 2013 Oct; 33(19):3849-63. PubMed ID: 23897427
[TBL] [Abstract][Full Text] [Related]
5. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
Yang X; Yang S; Wang C; Kuang S
J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
[TBL] [Abstract][Full Text] [Related]
6. Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.
Pawlus MR; Hu CJ
Cell Signal; 2013 Sep; 25(9):1895-903. PubMed ID: 23707522
[TBL] [Abstract][Full Text] [Related]
7. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
8. Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)-dependent stabilization of hypoxia-inducible factor 1-α and 2-α.
Yi Z; Jiang L; Zhao L; Zhou M; Ni Y; Yang Y; Yang H; Yang L; Zhang Q; Kuang Y; Deng M; Zhu Y
J Cell Biochem; 2019 Nov; 120(11):19124-19136. PubMed ID: 31310363
[TBL] [Abstract][Full Text] [Related]
9. Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity.
Bouthelier A; Meléndez-Rodríguez F; Urrutia AA; Aragonés J
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321829
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
[TBL] [Abstract][Full Text] [Related]
11. HIF1α and HIF2α independently activate SRC to promote melanoma metastases.
Hanna SC; Krishnan B; Bailey ST; Moschos SJ; Kuan PF; Shimamura T; Osborne LD; Siegel MB; Duncan LM; O'Brien ET; Superfine R; Miller CR; Simon MC; Wong KK; Kim WY
J Clin Invest; 2013 May; 123(5):2078-93. PubMed ID: 23563312
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
15. Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.
Fujii T; Nagamatsu T; Morita K; Schust DJ; Iriyama T; Komatsu A; Osuga Y; Fujii T
Sci Rep; 2017 Sep; 7(1):12455. PubMed ID: 28963486
[TBL] [Abstract][Full Text] [Related]
16. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.
Chachami G; Stankovic-Valentin N; Karagiota A; Basagianni A; Plessmann U; Urlaub H; Melchior F; Simos G
Mol Cell Proteomics; 2019 Jun; 18(6):1197-1209. PubMed ID: 30926672
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
[TBL] [Abstract][Full Text] [Related]
19. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.
Valli A; Rodriguez M; Moutsianas L; Fischer R; Fedele V; Huang HL; Van Stiphout R; Jones D; Mccarthy M; Vinaxia M; Igarashi K; Sato M; Soga T; Buffa F; Mccullagh J; Yanes O; Harris A; Kessler B
Oncotarget; 2015 Feb; 6(4):1920-41. PubMed ID: 25605240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]